Innoveren Scientific, Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Innoveren Scientific, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2023.
  • Innoveren Scientific, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$421K, a 77.3% increase year-over-year.
  • Innoveren Scientific, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$2.88M, a 30.1% increase year-over-year.
  • Innoveren Scientific, Inc. annual Operating Income (Loss) for 2022 was -$5.11M, a 3.4% increase from 2021.
  • Innoveren Scientific, Inc. annual Operating Income (Loss) for 2021 was -$5.29M, a 25.5% increase from 2020.
  • Innoveren Scientific, Inc. annual Operating Income (Loss) for 2020 was -$7.09M, a 76.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.88M -$421K +$1.43M +77.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 -$4.32M -$409K +$420K +50.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-15
Q1 2023 -$4.74M -$421K +$369K +46.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$5.11M -$1.63M -$982K -151% Oct 1, 2022 Dec 31, 2022 10-K 2023-05-10
Q3 2022 -$4.12M -$1.86M -$629K -51.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$3.5M -$829K +$1.18M +58.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-15
Q1 2022 -$4.67M -$790K +$613K +43.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$5.29M -$649K +$846K +56.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-05-10
Q3 2021 -$6.13M -$1.23M -$284K -30.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$5.85M -$2.01M -$83.1K -4.32% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$5.76M -$1.4M +$1.33M +48.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$7.09M -$1.49M +$16.8M +91.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$23.9M -$943K +$2.48M +72.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$26.4M -$1.92M +$3.3M +63.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$29.7M -$2.73M +$871K +24.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$30.6M -$18.3M -$16.3M -807% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$14.3M -$3.43M -$2.44M -248% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$11.8M -$5.22M -$4.9M -1528% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$6.93M -$3.6M -$2.73M -315% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-21
Q4 2018 -$4.19M -$2.02M -$404K -25.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-22
Q3 2018 -$3.79M -$985K +$381K +27.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.17M -$321K +$914K +74% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.08M -$868K +$979K +53% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.06M -$1.61M +$460K +22.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 -$6.52M -$1.37M +$370K +21.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$6.89M -$1.23M +$6.6M +84.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$13.5M -$1.85M -$630K -51.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$12.9M -$2.07M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$1.74M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$7.83M -$6.48M -481% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$1.22M +$237K +16.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q2 2015 -$1.35M Apr 1, 2015 Jun 30, 2015 10-Q 2016-11-17
Q1 2015 -$1.45M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.